National Cancer Institute
National Cancer Institute U.S. National Institutes of Health

Leukemia Steering Committee

The NCI Leukemia Steering Committee (LKSC) was established in 2009. Members of the LKSC include Cooperative Group leukemia committee chairs, representatives from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), Myelodysplastic Syndrome (MDS), Myeloproliferative Disorders (MPD) and Chronic Lymphocytic Leukemia (CLL) consortia, and investigators from Specialized Programs of Research Excellence (SPORE), Cancer Centers and R01/P01 grants along with community oncologists, biostatisticians, patient advocates and NCI staff.

Mission Statement

The LKSC follows an efficient, cost-effective, science-driven, and transparent process to identify and promote the "Best Science" in clinical research on leukemia and related diseases by addressing the design and prioritization of phase III trials and large phase II studies.

Roster of Leukemia Steering Committee members
Wendy Stock, M.D. and Jerry Radich, M.D., Co-chairs

Clinical Trial Planning Meetings (CTPMs): Goal of Clinical Trial Planning Meetings, and List of CTPM Executive Summaries and Publications

CCCT Contact: Lawrence Baizer, Ph.D.